Filter
786
Filtered Results: 786
Text search:
Relief
and
Development
Peer
Foundation
Featured
Recommendations
75
New Publications
218
Language
Document type
No document type
484
Studies & Reports
144
Guidelines
71
Manuals
50
Strategic & Response Plan
16
Situation Updates
7
Training Material
6
Resource Platforms
4
Fact sheets
3
Brochures
1
Countries / Regions
Global
31
Kenya
23
Myanmar / Burma
19
Nigeria
16
Rwanda
15
Tanzania
15
South Africa
15
Uganda
15
Ethiopia
15
Syria
14
Zambia
14
Malawi
12
India
12
Nepal
11
Africa
11
Western and Central Europe
10
Bangladesh
10
Liberia
10
Mozambique
9
Asia
9
Lesotho
8
Ghana
8
Sierra Leone
8
Zimbabwe
7
South Sudan
7
Indonesia
7
Ukraine
6
Philippines
6
Haiti
6
Senegal
5
Guinea
5
Latin America and the Carribbean
5
Germany
5
Congo, Democratic Republic of
5
Lebanon
5
Namibia
5
Yemen
5
China
4
Thailand
3
Cambodia
3
Jordan
3
Middle East and North Africa
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
East and Southern Africa
3
Vietnam
3
Russia
3
Sudan
3
Colombia
2
Mexico
2
Laos
2
Kyrgyzstan
2
USA
2
West and Central Africa
2
Western Pacific Region
2
Portugal
2
Eastern Europe
2
Brazil
2
Central African Republic
2
Botswana
2
Iraq
2
Eswatini/ Swaziland
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Serbia
1
Turkey
1
Cameroon
1
Iran
1
Burkina Faso
1
Malaysia
1
Morocco
1
Venezuela
1
Croatia
1
Hungary
1
Turkmenistan
1
Jamaica
1
Japan
1
Norway
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Southern Africa
1
Argentina
1
Moldova
1
Sri Lanka
1
Georgia
1
Mali
1
Angola
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
209
Key Resources
69
Women & Child Health
53
Public Health
50
Clinical Guidelines
49
Capacity Building
12
Pharmacy & Technologies
6
Toolboxes
HIV
115
Mental Health
85
Disability
55
COVID-19
50
TB
39
Conflict
32
Health Financing Toolbox
24
Caregiver
22
Planetary Health
21
NTDs
17
Global Health Education
17
Rapid Response
15
Natural Hazards
13
Refugee
12
AMR
9
Ebola & Marburg
8
Pharmacy
8
NCDs
6
Social Ethics
3
Polio
3
Cholera
2
Zika
2
Typhoon
1
The mhGAP community toolkit: field test version is an integral part of WHO's Mental Health Gap Action Programme (mhGAP), and aims at scaling up services for people with mental health conditions to achieve universal health coverage.
The toolkit provides guidance for programme managers on how to i...
Psoriasis, which can involve the skin, nails and joints, is a chronic, painful, disfiguring and disabling noncommunicable disease (NCD) for which there is no cure. It negatively impacts on quality of life. Some of those who suffer from the disease develop chronic, inflammatory arthritis (psoriatic a...
‘Psychosocial Support of Children in Emergencies’ is a reference document for humanitarian workers who want to increase their understanding of the experiences of children in emergency situations and how to support them in mitigating the negative effects of these experiences and how to prevent fu...
The assistive technology capacity assessment (ATA-C) is a system-level tool to evaluate a country’s capacity to finance, regulate, procure and provide assistive technology. It can be used for awareness raising, policy and programme design, and ongoing monitoring and evaluation. This manual provide...
Its main objectives are: to explain the educational approach underlying the Guide; to explain how to teach pharmacotherapy with the Guide; to give practical advice on how to assess the students, the teachers and the course; and to assist in mobilizing support for problem-based pharmacotherapy teachi...
Mental health is critically important to everyone, everywhere. All over the world, mental health needs are high but responses are insufficient and inadequate. The World mental health report: transforming mental health for all is designed to inspire and inform better mental health for everyone everyw...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3026 (Published 11 August 2020)
The BMJ "practice pointer" inlcudes a one-page visual summary of assessment and initial management of patients with persistant symptoms following acute SARS-CoV-2 infection
INEE pocket gu ide to inclusive education.
This guide is aimed at anyone working to provide, manage or support education services in emergencies and complements the INEE Minimum Standards.
The Pocket Guide to Inclusive Education outlines useful principles for an inclusive education approach in...
Mental health is critically important to everyone, everywhere. All over the world, mental health needs are high but responses are insufficient and inadequate. The World mental health report: transforming mental health for all is designed to inspire and inform better mental health for everyone everyw...
INTRODUCTION: The COVID-19 pandemic has disrupted health systems around the world. The objectives of this study are to estimate the overall effect of the pandemic on essential health service use and outcomes in Mexico, describe observed and predicted trends in services over 24 months, and to estimat...
WHO guideline on contact tracing
recommended
This practical guideline establishes definitions for “contact”, “contact person”, “contact tracing” and other associated concepts. It allows for improvement of contact tracing strategies and provides recommendations attempting to answer some, though not all, questions that arose during t...
The elimination scenario planning (ESP) manual provides malaria-endemic countries with a comprehensive framework to assess different scenarios for moving towards this goal, depending on programme coverage and funding availability. It also helps countries set realistic timelines and provides essentia...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The world is facing an unprecedented range of emergencies. In reaction to these complex adversities, many people experience considerable distress and impairment, and a minority may even go on to develop mental health conditions. Meanwhile, those with pre-existing mental health conditions may experie...
The COVID-19 pandemic led to school closures around the world, affecting almost 1.6 billion students. The effects of even short disruptions in a child’s schooling on their learning and well-being have been shown to be acute and long lasting. The capacities of education systems to respond to the cr...
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
Since the 1970s, voluntary contributions have become an increasingly important component of WHO's budget. As voluntary contributions tend to be earmarked for donor-specified programmes and projects, there are concerns that this trend has diverted focus away from WHO's strategic priorities, made coor...
2nd edition. The purpose of the WHO human health risk assessment toolkit: chemical hazards is to provide its users with guidance to identify, acquire and use the information needed to assess chemical hazards, exposures and the corresponding health risks in their given health risk assessment contexts...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ...
